Arnold M. Baskies - Mar 10, 2022 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Arnold M. Baskies
Stock symbol
ANIX
Transactions as of
Mar 10, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 03:15 PM
Previous filing
Jul 27, 2021
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +100K $0.00 100K Mar 10, 2022 Common Stock 100K $2.74 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in twelve (12) equal monthly installments beginning March 31, 2022.